Literature DB >> 28028724

Correlation study of basic Chinese medicine syndromes and neurotransmitter levels in patients with primary insomnia.

Rong Zhang1, Yun-Shuang Yang2, Xiao-Chen Liu2, Jin-Liang Yang2, Yan-Hui Li2, Peng-Zhan Shi2, Chao Yang3, Bin Qu2.   

Abstract

OBJECTIVE: To investigate the correlation between basic Chinese medicine (CM) syndromes (deficiency and excess syndromes) and intracranial neurotransmitter levels in primary insomnia (PI), to provide objective indicators and syndrome-based medical evidence for the differentiation of PI.
METHODS: A total of 158 patients with PI were recruited for CM syndrome differentiation. Another 30 healthy people without sleep disorders were selected as control group. An encephalofluctuograph analyzer was used to test the levels of intracranial neurotransmitters, including γ- aminobutyric acid (GABA), glutamate (Glu), 5-hydroxytryptamine (5-HT), dopamine (DA), etc., and their relevance were analyzed.
RESULTS: The neurotransmitter levels in the basic-deficiency group were lower than those in the healthy-control group, while the basic-excess group had higher levels than the healthy-control and basic-deficiency groups. Among the neurotransmitters, the 5-HT level was higher in the basic-excess group than in the basic-deficiency group (24.20±4.07 vs. 21.13±3.23; P<0.05); for the intermingled deficiency-excess group, the level of GABA was higher than that in the basic-deficiency group (9.48±3.07 vs. 7.23±3.67; P<0.05), Glu level was higher than that in the healthy-control group (7.53±4.10 vs. 5.83±0.99, P<0.05), and 5-HT and DA levels were lower than those in the healthy-control group (19.80±5.68 vs. 22.63±3.31, 5.27±3.79 vs. 6.83±1.58, respectively; P<0.05).
CONCLUSIONS: There was a correlation between the basic syndromes and intracranial neurotransmitter levels in patients with PI, which could objectively reflect the CM differentiation in PI. This information could be important for improving CM diagnosis and treatment in PI.

Entities:  

Keywords:  Chinese medicine syndrome; neurotransmitter; primary insomnia; syndrome differentiation

Year:  2016        PMID: 28028724     DOI: 10.1007/s11655-016-2752-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  2 in total

1.  Soporific Effect of Modified Suanzaoren Decoction and Its Effects on the Expression of CCK-8 and Orexin-A.

Authors:  Liang-Hui Zhan; Ying-Jie Dong; Ke Yang; Shan-Shan Lei; Bo Li; Xi Teng; Cong Zhou; Rong Luo; Qiao-Xian Yu; Hai-Ying Jin; Gui-Yuan Lv; Su-Hong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-16       Impact factor: 2.629

2.  Risk Factors and Clinical Manifestations of Juxtacortical Small Lesions: A Neuroimaging Study.

Authors:  Yilong Shan; Sha Tan; Yuge Wang; Kui Li; Lei Zhang; Siyuan Liao; Li Zhou; Zhezhi Deng; Xueqiang Hu; Haiyan Li; Xuejiao Men; Bingjun Zhang; Lisheng Peng; Zhuang Kang; Yan Zou; Zhengqi Lu
Journal:  Front Neurol       Date:  2017-09-22       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.